Pfizer plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK, after the business lists as an independent company in July, GSK said on Wednesday.
https://www.pharmalive.com/wp-content/uploads/2022/06/ReutersPfizer6-1-2022.jpg7741200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-06-01 11:20:072022-06-01 12:06:32Pfizer to sell stake in GSK’s consumer health business after it lists
